Stocks · Energy · Crude Petroleum & Natural Gas

Arcadia Biosciences, Inc.

RKDA Clue Score37
United States Fiscal year ends December CIK 0001469443
$0.26 -3.40% Close, 9 Oct 2026
Price $0.26 −87.04% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue3.2Operating income−18.6Net income−19.6Fiscal year 2017Revenue4.0 +26.3%Operating income−14.3Net income−15.7Fiscal year 2018Revenue1.5 −63.6%Operating income−16.9Net income−13.5Fiscal year 2019Revenue1.2 −20.2%Operating income−19.4Net income−28.8Fiscal year 2020Revenue8.0 +587.3%Operating income−12.8Net income−4.7Fiscal year 2021Revenue6.8 −15.6%Operating income−35.5Net income−14.7EPS, diluted−27.56Fiscal year 2022Revenue7.4 +9.4%Operating income−14.0Net income−15.4EPS, diluted−25.65Fiscal year 2023Revenue4.5 −40.0%Operating income−6.1Net income−14.0EPS, diluted−11.29Fiscal year 2024Revenue5.0 +13.3%Operating income−3.6Net income−7.0EPS, diluted−5.17Fiscal year 2025Revenue4.9 −3.7%Operating income−2.5Net income−2.3EPS, diluted−1.71
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 3.2 4.0 1.5 1.2 8.0 6.8 7.4 4.5 5.0 4.9
Growth +26.3% −63.6% −20.2% +587.3% −15.6% +9.4% −40.0% +13.3% −3.7%
Operating income −18.6 −14.3 −16.9 −19.4 −12.8 −35.5 −14.0 −6.1 −3.6 −2.5
Net income −19.6 −15.7 −13.5 −28.8 −4.7 −14.7 −15.4 −14.0 −7.0 −2.3
Growth
EPS, diluted n/a n/a n/a n/a n/a −27.56 −25.65 −11.29 −5.17 −1.71

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−584.1%Net margin−615.6%Free cash flow margin−542.2%Fiscal year 2017Operating margin−355.6%Net margin−390.1%Free cash flow margin−348.8%Fiscal year 2018Operating margin−1,152.3%Net margin−920.8%Free cash flow margin−948.2%Fiscal year 2019Operating margin−1,657.9%Net margin−2,464.1%Free cash flow margin−1,597.5%Fiscal year 2020Operating margin−159.0%Net margin−57.9%Free cash flow margin−405.2%Fiscal year 2021Operating margin−524.0%Net margin−216.2%Free cash flow margin−396.4%Fiscal year 2022Operating margin−188.8%Net margin−207.3%Free cash flow margin−189.4%Fiscal year 2023Operating margin−137.0%Net margin−313.9%Free cash flow margin−343.5%Fiscal year 2024Operating margin−72.3%Net margin−139.5%Free cash flow margin−191.1%Fiscal year 2025Operating margin−51.5%Net margin−48.1%Free cash flow margin−97.6%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −584.1% −355.6% −1,152.3% −1,657.9% −159.0% −524.0% −188.8% −137.0% −72.3% −51.5%
Net margin −615.6% −390.1% −920.8% −2,464.1% −57.9% −216.2% −207.3% −313.9% −139.5% −48.1%
Free cash flow margin −542.2% −348.8% −948.2% −1,597.5% −405.2% −396.4% −189.4% −343.5% −191.1% −97.6%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−17.1Capital expenditure−0.2Free cash flow−17.3Fiscal year 2017Operating cash flow−14.0Capital expenditure−0.1Free cash flow−14.0Fiscal year 2018Operating cash flow−13.6Capital expenditure−0.3Free cash flow−13.9Fiscal year 2019Operating cash flow−17.2Capital expenditure−1.5Free cash flow−18.7Fiscal year 2020Operating cash flow−30.2Capital expenditure−2.3Free cash flow−32.6Fiscal year 2021Operating cash flow−25.9Capital expenditure−1.0Free cash flow−26.9Fiscal year 2022Operating cash flow−14.0Capital expenditure−0.1Free cash flow−14.0Fiscal year 2023Operating cash flow−15.3Capital expenditure−0.0Free cash flow−15.3Fiscal year 2024Operating cash flow−9.6Capital expenditure−0.0Free cash flow−9.6Fiscal year 2025Operating cash flow−4.7Capital expenditure0.0Free cash flow−4.7
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −17.1 −14.0 −13.6 −17.2 −30.2 −25.9 −14.0 −15.3 −9.6 −4.7
Capital expenditure −0.2 −0.1 −0.3 −1.5 −2.3 −1.0 −0.1 −0.0 −0.0 0.0
Free cash flow −17.3 −14.0 −13.9 −18.7 −32.6 −26.9 −14.0 −15.3 −9.6 −4.7
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash2.0Total debt25.1Net cash (debt)−23.1Shareholders’ equity22.2Debt to equity1.13Fiscal year 2017Cash9.1Total debt0.0Net cash (debt)9.1Shareholders’ equity8.0Debt to equity0.00Fiscal year 2018Cash12.0Total debt0.0Net cash (debt)12.0Shareholders’ equity12.8Debt to equity0.00Fiscal year 2019Cash8.4Total debt0.1Net cash (debt)8.3Shareholders’ equity7.7Debt to equity0.01Fiscal year 2020Cash14.0Total debt2.1Net cash (debt)11.9Shareholders’ equity27.7Debt to equity0.08Fiscal year 2021Cash28.7Total debt0.0Net cash (debt)28.7Shareholders’ equity31.1Debt to equity0.00Fiscal year 2022Cash20.6Shareholders’ equity21.0Fiscal year 2023Cash6.5Shareholders’ equity12.8Fiscal year 2024Cash4.2Shareholders’ equity6.2Fiscal year 2025Cash0.3Shareholders’ equity4.1
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 2.0 9.1 12.0 8.4 14.0 28.7 20.6 6.5 4.2 0.3
Total debt 25.1 0.0 0.0 0.1 2.1 0.0 n/a n/a n/a n/a
Net cash (debt) −23.1 9.1 12.0 8.3 11.9 28.7 n/a n/a n/a n/a
Shareholders’ equity 22.2 8.0 12.8 7.7 27.7 31.1 21.0 12.8 6.2 4.1
Debt to equity 1.13 0.00 0.00 0.01 0.08 0.00 n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023† 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
3.2 4.0 1.5 1.2 8.0 6.8 7.4 4.5 5.0 4.9
Growth +26.3% −63.6% −20.2% +587.3% −15.6% +9.4% −40.0% +13.3% −3.7%
n/a n/a n/a n/a 5.2 8.7 6.1 2.2 3.0 3.1
8.7 7.4 6.1 7.1 8.0 3.9 1.5 0.1 0.1 0.0
12.3 10.7 11.6 13.6 16.5 22.9 15.0 8.2 9.6 7.0
−18.6 −14.3 −16.9 −19.4 −12.8 −35.5 −14.0 −6.1 −3.6 −2.5
Growth
−19.6 −15.7 −13.5 −28.9 −6.2 −16.1 −10.8 −5.3 −4.3 −2.3
0.0 0.0 0.0 0.0 −0.1 0.0 0.0 0.0 0.0 0.0
−19.6 −15.7 −13.5 −28.8 −4.7 −14.7 −15.4 −14.0 −7.0 −2.3
Growth
Per share
n/a n/a n/a n/a n/a −27.56 −25.65 −11.29 −5.17 −1.71
n/a n/a n/a n/a n/a −27.56 −25.65 −11.29 −5.17 −1.71
Growth
n/a n/a n/a n/a n/a 0.5 0.6 1.2 1.4 1.4
n/a n/a n/a n/a n/a 0.5 0.6 1.2 1.4 1.4
Growth +12.7% +106.4% +10.2% +0.3%

† The diluted share count jumps at 2023, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 9.6% a year over five years.
  • Operating margin is up 107.6 points on five years ago, at -51.5%.
  • A net loss in 10 of 10 years on file.